AFP and hepatocellular carcinoma: Alpha-fetoprotein (AFP), a serologic biomarker used for decades to screen and diagnose HCC, is currently not recommended by American and European guidelines [2,3] due to the inadequate sensitivity (61%) and specificity (71%) when combined with ultrasound.